Equity Overview
Price & Market Data
Price: $0.0₃1
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $6,165
Daily Volume: 0
Company Details
Employees: 2
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
NovAccess Global Inc., a biopharmaceutical company, engages in the development of novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in New York, New York.